When Vaccination Stands Between a Patient and Their Therapy
Back to All Naven Health News
For a patient who is already managing a serious condition, one more appointment is a real burden. Arranging travel, time and coordination for a vaccination visit can push back the start of therapy. The clinical need is clear, but the logistics can get in the way.
This is the kind of barrier that gets more attention as pharmaceutical manufacturers look for ways to reduce treatment delays.
Bringing vaccination into the home
Naven has delivered in-home vaccine administration for this kind of program. A nurse comes to the patient, allowing vaccination to be completed in the home. Vaccination often runs as a series of doses with boosters, and Naven meets patients wherever they are in that series.
Behind each visit is a consistent model. Nurses are trained on the program and the specific vaccines they give, with competency verified before they see a patient. Each administration record is quality-checked and sent to the ordering physician within 24 business hours. Partners get clear reporting on visit completion and patient feedback throughout.
The in-home vaccination program’s results reflect that consistency. Across more than 1,700 in-home visits, the program has held a 0% Naven-attributable cancellation rate and an average 95% patient satisfaction.
What this means for partners
Each step supported between approval and treatment is one less thing a patient has to navigate alone. In-home vaccine administration helps patients complete an important therapy prerequisite and helps keep therapy on schedule.
That step is one Naven can take on. Naven delivers in-home vaccine administration as part of its wraparound clinical services, -the clinical work that surrounds therapy administration and helps support the path to treatment all backed by one of the nation’s largest nursing networks across all 50 states.
Download the case study to learn more about Naven Health’s in-home vaccine administration program.
Naven News
Helping Patients Get On Treatment Faster
For pharmaceutical manufacturers and life science partners, bringing a therapy to market is only part of the access challenge. Coverage and approval open the door, but they don’t clear everything standing between a patient and treatment. Patients can still be left with lab work they need to complete first, vaccines they need before starting and […]

Bringing the Trial to the Patient: Nursing Support for Decentralized Clinical Trials in Pediatric Rare Disease
Recruiting and retaining patients for a clinical trial in pediatric rare disease can be challenging. Patient populations are small, families are geographically dispersed, and the burden of repeated travel to a trial site can stretch families thin over the course of a multi-year study. When a child also faces physical and cognitive challenges, the demands […]